Evogene Reports Slight YoY Boost In Q3 Revenue, Looks To Turn Subsidiaries Into Public CompaniesBenzinga • 11/17/21
Evogene Announces Participation in the Second Research Period of the CRISPR-IL ConsortiumPRNewsWire • 11/10/21
Lavie Bio Announces Commercial Launch of its First Microbiome-Based Product for Yield Improvement - result™PRNewsWire • 11/03/21
Biomica & Rambam Health Care Campus Sign Agreement for Clinical Trial of Biomica's Microbiome-Based Immuno-Oncology DrugPRNewsWire • 10/27/21
Evogene Financial Results and Earnings Announcement Schedule for the Third Quarter of 2021PRNewsWire • 10/27/21
Evogene's Canonic Launches First Two Medical Cannabis Products In Israel Ahead Of ScheduleBenzinga • 10/19/21
Canonic Announces Full Commercial Launch of its First Medical Cannabis Products in IsraelPRNewsWire • 10/19/21
Lavie Bio and United Agronomy Announce Signing of Distribution Agreement for Lavie Bio's Inoculant ProductPRNewsWire • 09/29/21
Evogene to Present at Cantor Virtual Global Healthcare Conference, September 2021PRNewsWire • 09/14/21
Evogene to Present at H.C. Wainwright 23rd Annual Global Investment Conference - 2021PRNewsWire • 09/01/21
Canonic Announces Pre-Launch of its First Generation Medical Cannabis Products in IsraelPRNewsWire • 08/31/21
Evogene Ltd. (EVGN) CEO Ofer Haviv on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/11/21
Evogene Reports $135.000 In Q2 2021 Revenue, Misses Estimates, EPS Beat Projections By $0.02Benzinga • 08/11/21
Evogene Financial Results and Earnings Announcement Schedule for the Second Quarter of 2021PRNewsWire • 07/28/21
AgPlenus Announces Positive Results for a Herbicide Resistance Trait to its Leading Herbicide Product CandidatePRNewsWire • 07/06/21